Celcuity (CELC) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

CELC Stock Forecast


Celcuity stock forecast is as follows: an average price target of $31.50 (represents a 105.08% upside from CELC’s last price of $15.36) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.

CELC Price Target


The average price target for Celcuity (CELC) is $31.50 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $39.00 to $24.00. This represents a potential 105.08% upside from CELC's last price of $15.36.

CELC Analyst Ratings


Buy

According to 5 Wall Street analysts, Celcuity's rating consensus is 'Buy'. The analyst rating breakdown for CELC stock is 0 'Strong Buy' (0.00%), 5 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Celcuity Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 15, 2024Bradley CaninoStifel Nicolaus$39.00$16.57135.37%153.91%
May 30, 2024Bradley CaninoStifel Nicolaus$40.00$15.28161.78%160.42%
Mar 28, 2024Gil BlumNeedham$24.00$18.1632.16%56.25%
Row per page
Go to

The latest Celcuity stock forecast, released on Aug 15, 2024 by Bradley Canino from Stifel Nicolaus, set a price target of $39.00, which represents a 135.37% increase from the stock price at the time of the forecast ($16.57), and a 153.91% increase from CELC last price ($15.36).

Celcuity Price Target by Period


1M3M12M
# Anlaysts-13
Avg Price Target-$39.00$34.33
Last Closing Price$15.36$15.36$15.36
Upside/Downside-100.00%153.91%123.50%

In the current month, the average price target of Celcuity stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Celcuity's last price of $15.36. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Aug 15, 2024Cowen & Co.BuyBuyHold
Jul 22, 2024JefferiesBuyBuyHold
Mar 28, 2024Craig-HallumBuyBuyHold
Mar 28, 2024NeedhamBuyBuyHold
Oct 11, 2021Canaccord Genuity-BuyInitialise
Row per page
Go to

Celcuity's last stock rating was published by Cowen & Co. on Aug 15, 2024. The company gave CELC a "Buy" rating, the same as its previous rate.

Celcuity Financial Forecast


Celcuity Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
Revenue-----------
Avg Forecast$28.60M$14.30M$92.80M$92.80M$1.27M$550.00K--$4.41M$1.89M-
High Forecast$28.60M$14.30M$92.80M$92.80M$1.27M$550.00K--$4.41M$1.89M-
Low Forecast$28.60M$14.30M$92.80M$92.80M$1.27M$550.00K--$4.41M$1.89M-
# Analysts444433--45-
Surprise %-----------

Celcuity's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. CELC's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Celcuity EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts444433--45-
EBITDA-----------
Avg Forecast-----------
High Forecast-----------
Low Forecast-----------
Surprise %-----------

undefined analysts predict CELC's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Celcuity's previous annual EBITDA (undefined) of $NaN.

Celcuity Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts444433--45-
Net Income-----------
Avg Forecast$-21.14M$-28.45M$-34.22M$-30.37M$-32.99M$-31.29M$-30.06M$-28.14M$-27.13M$-25.10M$-26.09M
High Forecast$-21.14M$-28.45M$-34.22M$-30.37M$-32.99M$-31.29M$-30.06M$-28.14M$-27.13M$-21.24M$-26.09M
Low Forecast$-21.14M$-28.45M$-34.22M$-30.37M$-32.99M$-31.29M$-30.06M$-28.14M$-27.13M$-27.80M$-26.09M
Surprise %-----------

Celcuity's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CELC's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Celcuity SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts444433--45-
SG&A-----------
Avg Forecast-----------
High Forecast-----------
Low Forecast-----------
Surprise %-----------

Celcuity's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to CELC last annual SG&A of $NaN (undefined).

Celcuity EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts444433--45-
EPS-----------
Avg Forecast$-0.55$-0.74$-0.89$-0.79$-0.86$-0.81$-0.78$-0.73$-0.71$-0.65$-0.68
High Forecast$-0.55$-0.74$-0.89$-0.79$-0.86$-0.81$-0.78$-0.73$-0.71$-0.55$-0.68
Low Forecast$-0.55$-0.74$-0.89$-0.79$-0.86$-0.81$-0.78$-0.73$-0.71$-0.72$-0.68
Surprise %-----------

According to undefined Wall Street analysts, Celcuity's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CELC previous annual EPS of $NaN (undefined).

Celcuity Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ANTXAN2 Therapeutics$1.08$8.75710.19%Buy
HOWLWerewolf Therapeutics$2.26$12.00430.97%Buy
MOLNMolecular Partners$6.06$29.00378.55%Buy
AVTEAerovate Therapeutics$2.72$13.00377.94%Hold
ANEBAnebulo Pharmaceuticals$1.89$6.00217.46%Buy
ACRVAcrivon Therapeutics$7.85$22.00180.25%Buy
ANABAnaptysBio$19.94$52.33162.44%Buy
RZLTRezolute$5.44$13.50148.16%Buy
MLYSMineralys Therapeutics$13.50$30.00122.22%Buy
CCCCC4 Therapeutics$6.45$13.50109.30%Buy
CELCCelcuity$15.36$31.50105.08%Buy
ADAGAdagene$3.05$5.0063.93%Buy
EWTXEdgewise Therapeutics$34.48$45.0030.51%Buy
IKNAIkena Oncology$1.72$1.33-22.67%Buy
CYTCyteir Therapeutics$3.02$2.00-33.77%Sell

CELC Forecast FAQ


Yes, according to 5 Wall Street analysts, Celcuity (CELC) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 100.00% of CELC's total ratings.

Celcuity (CELC) average price target is $31.5 with a range of $24 to $39, implying a 105.08% from its last price of $15.36. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for CELC stock, the company can go up by 105.08% (from the last price of $15.36 to the average price target of $31.5), up by 153.91% based on the highest stock price target, and up by 56.25% based on the lowest stock price target.

CELC's average twelve months analyst stock price target of $31.5 supports the claim that Celcuity can reach $20 in the near future.

Celcuity's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.82M (high $1.82M, low $1.82M), average EBITDA is $0 (high $0, low $0), average net income is $-122M (high $-122M, low $-122M), average SG&A $0 (high $0, low $0), and average EPS is $-3.186 (high $-3.186, low $-3.186). CELC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $228.5M (high $228.5M, low $228.5M), average EBITDA is $0 (high $0, low $0), average net income is $-114M (high $-114M, low $-114M), average SG&A $0 (high $0, low $0), and average EPS is $-2.97 (high $-2.97, low $-2.97).